Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.64 is 61% below its 5-year average of 6.79, near the low end of its 5-year range (0.60–36.42).
As of the fiscal period ended Tuesday, June 30, 2026. 43.70% below its 12-month average of 4.70.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.64.
CURRENT RATIO
2.64
CURRENT RATIO AVG TTM
4.70
CURRENT RATIO AVG 3Y
10.51
CURRENT RATIO AVG 5Y
6.79
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-43.70%
CURRENT VS 3Y AVG
-74.85%
CURRENT VS 5Y AVG
-61.06%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-29.50%
vs the sector median at left
CytoMed Therapeutics Limited
Market Cap
$11.00M
Current Ratio
2.64
TTM Avg
4.70
3Y Avg
10.51
5Y Avg
6.79
Market Cap
$11.02M
Current Ratio
3.69
TTM Avg
5.96
3Y Avg
7.84
5Y Avg
10.45
Market Cap
$11.08M
Current Ratio
8.97
TTM Avg
5.46
3Y Avg
4.04
5Y Avg
3.77
Market Cap
$11.12M
Current Ratio
3.07
TTM Avg
5.09
3Y Avg
9.39
5Y Avg
12.46
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CytoMed Therapeutics Limited (GDTC) | $11.00M | 2.64 | 4.70 | 10.51 | 6.79 |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.02M | 3.69 | 5.96 | 7.84 | 10.45 |
| Cerenome, Inc. (CNSY)vs › | $10.94M | 1.37 | 0.79 | 1.08 | 1.46 |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.08M | 8.97 | 5.46 | 4.04 | 3.77 |
| VistaGen Therapeutics, Inc. (VTGN)vs › | $11.12M | 3.07 | 5.09 | 9.39 | 12.46 |
| BioVie Inc. (BIVI)vs › | $10.86M | 3.59 | 6.34 | 4.40 | 4.46 |
| Polyrizon Ltd. (PLRZ)vs › | $10.83M | 36.37 | 19.59 | 9.84 | 7.09 |
| Pluri Inc. (PLUR)vs › | $10.68M | 0.27 | 0.48 | 3.83 | 4.93 |
| Caring Brands, Inc. (CABR)vs › | $11.36M | 4.96 | 13.16 | 13.16 | 13.16 |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.55M | 15.87 | 27.51 | 16.79 | 13.69 |
Current Ratio
2.64
Quick Ratio
2.64
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.64 |
| 2025-12-31 | 5.17 |
| 2025-09-30 | 5.17 |
| 2025-06-30 | 5.81 |
| 2025-03-31 | 5.81 |
| 2024-12-31 | 9.89 |
| 2024-09-30 | 9.89 |
| 2024-06-30 | 21.53 |
| 2024-03-31 | 21.53 |
| 2023-12-31 | 14.08 |
| 2023-09-30 | 14.08 |
| 2023-06-30 | 36.42 |
| 2023-03-31 | 36.42 |
| 2022-12-31 | 0.60 |
| 2022-09-30 | 0.60 |
| 2022-06-30 | 0.72 |
| 2022-03-31 | 0.72 |
| 2021-12-31 | 1.12 |
| 2021-09-30 | 1.12 |
| 2021-06-30 | 1.73 |
| 2021-03-31 | 1.73 |
| 2020-12-31 | 0.54 |
| 2020-09-30 | 0.54 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
